University Medical Center Groningen
Groningen, 9700RB, Netherlands
NCT Number: NCT02588222
The purpose of this study is to establish reliable reference intervals for fecal S100A12 in healthy children.
Looking for future studies?
Notify Me6 year–18 year
All sexes
Observational
Groningen, 9700RB, Netherlands
RATIONALE S100A12 (calgranulin C) is a cytoplasmic protein secreted exclusively by activated neutrophils. It can be measured in stools and elevated levels are observed in children with inflammatory bowel disease. The protein is stable in stool samples for up to seven days at room temperature, which allows collection at home and potential delays in transport to the laboratory. S100A12 could be used as a marker to discriminate between pediatric inflammatory and functional gastro-intestinal conditions, and prevent children with a low probability of inflammation from unnecessary endoscopic procedures. Until now a reliable reference interval for healthy children is lacking.
OBJECTIVE To establish reliable reference intervals for fecal S100A12 in healthy children.
TIME FRAME Healthy children will be asked to send in one feces sample anonymously during the inclusion period. The investigators expect that the required 120 samples will be collected before December 2015. There will be no follow up of patients.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
healthy volunteers:
Exclusion criteria
Time frame: One measurement at baseline
University Medical Center Groningen
Other
Acronym: GRINCH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02136745
Colonic Diseases, Colonic Diseases, Functional
Boston, Massachusetts, United States
View Trial DetailsNCT02847052
Digestive System Diseases, Gastroenteritis
Nantes, France
View Trial DetailsNCT04060303
Colitis, Colitis, Ulcerative
Chicago, Illinois, United States
View Trial DetailsNCT02341742
Behavior, Digestive System Diseases
Lille, Nord, France
View Trial Details